Aperio Group’s Akso Health Group AHG Stock Holding History

Aperio Group’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-65	Closed	–	–	2312
2019 Q2	$0	Buy	+65	New	+$542	﹤0.01%	3020

Other funds holding AHG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Aperio Group's AHG Position: Q3 2019 in Review

Aperio Group sold out of Akso Health Group (AHG) in Q3 2019, closing a stake of 65 shares.

Aperio Group first reported a position in AHG in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 11 funds tracked by Wall St. Rank hold AHG as of Q3 2019.

Aperio Group reported no remaining Akso Health Group position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 65 Akso Health Group shares in Q3 2019.
Aperio Group first reported a position in Akso Health Group in Q2 2019 and held it in 1 quarter.
Aperio Group's Akso Health Group position peaked at $0 in Q2 2019.
11 funds tracked by Wall St. Rank held Akso Health Group as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.